title: Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.
abstract: A phase II trial of fludarabine phosphate using a bolus and continuous infusion regimen in previously treated multiple myeloma was performed. No responses were observed in eleven patients. There was no significant non-hematologic toxicity noted. Fludarabine phosphate is inactive in multiple myeloma using this schedule.
authors.affiliation: a From: Don Monti Division of Oncology, Department of Medicine, Department of Medicine, North Shore University Hospital-Cornell University Medical College, Manhasset, NY, Cornell University Medical College, New York.
authors.forename: S M
authors.initials: SM
authors.lastname: Lichtman
authors.affiliation: b Division of Neoplastic Diseases, Department of Medicine, New York Medical College, Valhalla, New York, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mittelman
authors.affiliation: a From: Don Monti Division of Oncology, Department of Medicine, Department of Medicine, North Shore University Hospital-Cornell University Medical College, Manhasset, NY, Cornell University Medical College, New York.
authors.forename: D R
authors.initials: DR
authors.lastname: Budman
authors.affiliation: b Division of Neoplastic Diseases, Department of Medicine, New York Medical College, Valhalla, New York, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Puccio
authors.affiliation: c Investigational Drug Branch, Cancer Therapy Evaluation Program Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland, USA.|d Division of Neoplastic Diseases, New York Medical College, Valhalla, New York.
authors.forename: H G
authors.initials: HG
authors.lastname: Chun
authors.affiliation: a From: Don Monti Division of Oncology, Department of Medicine, Department of Medicine, North Shore University Hospital-Cornell University Medical College, Manhasset, NY, Cornell University Medical College, New York.
authors.forename: S L
authors.initials: SL
authors.lastname: Allen
authors.affiliation: b Division of Neoplastic Diseases, Department of Medicine, New York Medical College, Valhalla, New York, USA.
authors.forename: T
authors.initials: T
authors.lastname: Ahmed
authors.affiliation: b Division of Neoplastic Diseases, Department of Medicine, New York Medical College, Valhalla, New York, USA.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Arlin
keywords: fludarabine phosphate; multiple myeloma